It is possible that the continued synthesis of dNTPs in dividing HeLa does not allow SAMHD1 dNTPase activity to sufficiently lower the cellular dNTP pool for lentiviral restriction to occur. SAMHD1 function but further support the notion that SAMHD1 possesses an additional dNTP-independent function contributing to lentiviral restriction. However , our own experiments failed to associate this presumed additional SAMHD1 antiviral activity with a reported nuclease activity. Keywords: SAMHD1, HIV-1, SIV, dATP, dNTPase, nuclease, restriction == INTRODUCTION == Sterile alpha motif and HD domain protein 1 (SAMHD1) is a sponsor factor contributing to the inefficient replication of HIV-1 in cells of myeloid lineage and other non-dividing cell types (Baldauf et al., 2012; Berger et al., 2011; Descours et al., Rabbit polyclonal to PHF13 2012; Hrecka et al., 2011; Laguette et al., 2011). The SIVsm/HIV-2 Vpx proteins are however able to counteract SAMHD1 by targeting it for proteasomal degradation and viruses lacking this protein are restricted at the reverse transcription step in susceptible cell types (Goujon et al., 2007; Hrecka et al., 2011; Laguette et al., 2011; Sharova et al., 2008). Early work on the SAMHD1 protein suggested it to be involved in regulating the innate immune response as mutations in SAMHD1 have been associated with Acardi-Goutieres Syndrome (AGS), a syndrome associated with increased production HA-1077 dihydrochloride of interferon alpha (Dussaix et al., 1985; Rice et al., 2009). Accordingly, SAMHD1 knockout mice, while developmentally healthy, show increased expression of interferon stimulated genes (Behrendt et al., 2013; Rehwinkel et al., 2013). The main catalytic activity ascribed to SAMHD1 is its (d)GTP-dependent dNTPase activity with an active site located in the proteins HD domain (Amie et al., 2013; Goldstone et al., 2011; Hansen et al., 2014; Ji et al., 2014; Ji et al., 2013; Koharudin et al., 2014; Powell et al., 2011; Zhu et al., 2013). This enzymatic activity allows SAMHD1 to degrade dNTPs to component nucleosides and free triphosphate in a single step. Therefore , dNTP degradation by SAMHD1 provides a counterpart to dNTP synthesis by ribonucleotide reductase (RNR) with both these proteins being carefully regulated to control the delicate dNTP balance in cells (Franzolin et al., 2013). It was thus suggested that SAMHD1 uses its dNTPase activity to restrict lentivirus (and other dNTP-dependent virus) infection by decreasing dNTP levels in susceptible cells to below the levels required for reverse transcription/replication (Hollenbaugh et al., 2013; Kim et al., 2012; Kim et al., 2013; Lahouassa et al., 2012). Interestingly, SAMHD1 also possesses nucleic acid binding capability and has been reported in some studies to possess 35 exonuclease activity against ssRNA and viral genomes (Beloglazova et al., 2013; Goncalves et al., 2012; Ryoo et al., 2014; Tungler et al., 2013; White et al., 2013a). Indeed, several recent reports employing mutagenesis experiments to genetically separate the HA-1077 dihydrochloride dNTPase and nuclease activities of the protein suggested that nuclease activity may be the main contributor to SAMHD1 restriction of lentiviruses (Choi et al., 2015; Ryoo et al., 2014). However , other studies have failed to detect nuclease activity associated with the SAMHD1 active site (Goldstone et al., 2011; Seamon et al., 2015) thus, leaving the question of the functional importance of a SAMHD1 exonuclease activity up for future investigations. Furthermore, while phosphorylation has been shown to negatively regulate SAMHD1 restriction ability (Cribier et al., 2013; Welbourn et al., 2013; White et al., 2013b) it is still unclear whether this modification might affect dNTPase activity, nuclease activity or possibly another characteristic of SAMHD1 not yet described (Arnold et al., 2015; Ryoo et al., 2014; Tang et al., 2015; Welbourn et al., 2013; White et al., 2013b; Yan et al., 2015). Therefore , whether lowering cellular dNTP levels is the sole mechanism of restriction used by SAMHD1 and whether or not this function is even necessary requires further investigation. In this study we investigated the importance of cellular dNTP levels for virus restriction by SAMHD1. Unlike other restriction factors such as APOBEC3G that renders normally permissive HA-1077 dihydrochloride HeLa cells restrictive for HIV-1, exogenous expression of SAMHD1 in HeLa cells shows little to no restrictive phenotype. It is possible that the continued synthesis of dNTPs in dividing HeLa does not allow SAMHD1 dNTPase activity to sufficiently lower the cellular dNTP pool for lentiviral restriction to occur. Alternatively, it cannot be ruled out that SAMHD1 applies its virocide effect in partnership with additional lot factor(s) certainly not expressed in non-myeloid or perhaps dividing cellular types. To cope with these problems, we implemented SAMHD1 options together with hydroxyurea treatment to modulate dNTP levels in HeLa skin cells. Hydroxyurea prevents ribonucleotide reductase and thus minimizes the mobile phone dNTP pool area at the activity step (Nordlund and Reichard, 2006). Drive of mobile phone dATP amounts confirmed that hydroxyurea noticeably reduced the baseline dNTP pool in treated HeLa cells with SAMHD1 demonstrating negligible more effects relating to the dNTP pool area. Using the hydroxyurea strategy of lowering base dNTP amounts we were allowed to demonstrate SAMHD1 antiviral activity in HeLa cells although no more antiviral activity was demonstrable in HA-1077 dihydrochloride neglected cells. These kinds of results claim that the lack of virocide activity of SAMHD1 in natural HeLa skin HA-1077 dihydrochloride cells is certainly not due to the deficiency of additional.